全文获取类型
收费全文 | 29837篇 |
免费 | 2839篇 |
国内免费 | 560篇 |
专业分类
耳鼻咽喉 | 126篇 |
儿科学 | 351篇 |
妇产科学 | 336篇 |
基础医学 | 2463篇 |
口腔科学 | 193篇 |
临床医学 | 2116篇 |
内科学 | 2647篇 |
皮肤病学 | 373篇 |
神经病学 | 674篇 |
特种医学 | 1334篇 |
外国民族医学 | 22篇 |
外科学 | 11833篇 |
综合类 | 2944篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 662篇 |
眼科学 | 112篇 |
药学 | 1199篇 |
12篇 | |
中国医学 | 224篇 |
肿瘤学 | 5612篇 |
出版年
2024年 | 37篇 |
2023年 | 429篇 |
2022年 | 578篇 |
2021年 | 1141篇 |
2020年 | 1192篇 |
2019年 | 1155篇 |
2018年 | 1146篇 |
2017年 | 1104篇 |
2016年 | 1135篇 |
2015年 | 1341篇 |
2014年 | 1924篇 |
2013年 | 2073篇 |
2012年 | 1655篇 |
2011年 | 1726篇 |
2010年 | 1553篇 |
2009年 | 1571篇 |
2008年 | 1606篇 |
2007年 | 1598篇 |
2006年 | 1405篇 |
2005年 | 1299篇 |
2004年 | 1152篇 |
2003年 | 919篇 |
2002年 | 773篇 |
2001年 | 634篇 |
2000年 | 394篇 |
1999年 | 328篇 |
1998年 | 414篇 |
1997年 | 345篇 |
1996年 | 323篇 |
1995年 | 251篇 |
1994年 | 218篇 |
1993年 | 188篇 |
1992年 | 160篇 |
1991年 | 166篇 |
1990年 | 134篇 |
1989年 | 123篇 |
1988年 | 123篇 |
1987年 | 110篇 |
1986年 | 97篇 |
1985年 | 138篇 |
1984年 | 100篇 |
1983年 | 78篇 |
1982年 | 86篇 |
1981年 | 69篇 |
1980年 | 74篇 |
1979年 | 43篇 |
1978年 | 40篇 |
1977年 | 34篇 |
1976年 | 18篇 |
1975年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
62.
目的 总结和评价经直肠超声引导下前列腺穿刺活检术对前列腺癌诊断的准确率。方法 222 例直肠指检阳性或 PSA>4μg/L的患者应用经直肠超声引导下前列腺6点系统穿刺活检以明确诊断。结果 222 例受检者中病理证实前列腺结节性增生41例、前列腺炎24例、前列腺肉瘤3例、前列腺癌 154 例,其中低分化癌 74 例、中分化癌 58 例、高分化癌 22 例。术后血尿15例、发热6例,其中高热1例,经抗生素治疗后体温恢复正常、尿检阴性。结论 经直肠超声引导下前列腺穿刺活检无需麻醉,患者痛苦小、安全性高,是诊断前列腺癌的可靠方法。 相似文献
63.
64.
We report a case of extragastrointestinal stromal tumor possibly originating from the prostate. The patient underwent radical prostatectomy because of no metastatic evidence. No recurrence and metastasis have been found during 14 months of follow up. To our knowledge, this may be the third such case published in a report in terms of pathological type. 相似文献
65.
66.
Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer 总被引:1,自引:1,他引:0
Toshikazu Okaneya Shuji Nishizawa Tsuyoshi Nakayama Takayuki Kamigaito Iwao Hashida Noriko Hosaka 《International journal of urology》2007,14(7):602-606
OBJECTIVE: To evaluate the initial results of brachytherapy for prostate cancer with permanent iodine-125 implant in Japan. METHODS: The results obtained with brachytherapy in the initial 100 Japanese patients treated at Nagano Municipal Hospital were reviewed. Patients with a prostate-specific antigen (PSA) level of less than 10 ng/mL and a Gleason's scores of 5, 6, 3 + 4 were classified as having a low risk of recurrence. Patients with a PSA level of 10-20 ng/mL and/or a Gleason's score of 4 + 3 were classified as having an intermediate risk for recurrence. Seventy-eight of the low-risk patients and 19 of the intermediate-risk patients were treated by seed implants alone, or seed implants combined with preceding external radiation, respectively. A total of 53 patients received neoadjuvant hormone therapy. The efficacy and morbidity of brachytherapy were investigated using the serum PSA, International Prostate Symptom Score, quality of life score and uroflowmetry data. RESULTS: The average V100 and D90 obtained by post-implant dosimetry was 94.3 and 113.7%, respectively. Serum PSA decreased gradually after treatment, although it had still not reached a nadir after 1 year. There was little difference of the PSA level between the patients with and without neoadjuvant hormone therapy even at 1 year after seed implantation. There were no PSA biochemical failure or clinical recurrence during the follow-up period. Voiding symptoms worsened until 3 months after treatment, and then gradually improved. Acute urinary retention occurred transiently in one patient (1%). Rectal bleeding and severe diarrhea did not occur. CONCLUSION: Brachytherapy is a feasible and effective option for the treatment of prostate cancer in Japanese men. Brachytherapy may have a different effect in Japanese patients with respect to voiding symptoms. Urinary retention was rare, but voiding symptoms were persistent in Japanese patients. Neoadjuvant hormone therapy deserves investigation to determine whether it can achieve better results, especially in patients with an intermediate risk. 相似文献
67.
68.
69.
Katsumi Shigemura Soichi Arakawa Kunito Yamanaka Nobuo Kataoka Keiji Yuien Masato Fujisawa 《International journal of urology》2007,14(10):935-938
OBJECTIVES: Lateral biopsies are thought to have a better cancer detection rate compared with standard sextant biopsies. This study aimed to determine whether lateral peripheral zone biopsies in Japanese men who underwent transrectal ultrasound-guided prostate biopsies provided a significantly higher cancer detection rate than sextant biopsies. METHODS: Between 1999 and 2004, data were collected from 461 men who underwent prostate biopsy and had enough data regarding the performance of lateral biopsies for statistical analysis. There were two categories in this study: (i) patients who underwent sextant prostate biopsies; and (ii) patients who underwent sextant biopsies plus lateral biopsies. RESULTS: Prostate cancer was detected in 141 (30.6%) of 461 patients. It was detected in 24 (22.2%) of 108 patients who underwent sextant biopsies and 117 (33.1%) of 353 patients who underwent sextant plus lateral biopsies. Lateral biopsies were not associated with a statistically higher rate of positive biopsy findings; however, we found a significantly higher ratio of patients with positive findings in those with prostate specific antigen (PSA) levels 10 ng/mL (one of 71, 1.4%) among those who had positive cores only in lateral biopsy samples (P < 0.0001). CONCLUSIONS: Lateral biopsies did not show a significantly higher detection ratio of prostate cancer compared to sextant biopsies. However, lateral biopsies were more effective than sextant biopsies in patients with lower PSA levels. Our findings might be useful for the establishment of biopsy strategies to detect prostate cancer, especially in patients with lower PSA levels. 相似文献
70.
SUNG-GOO CHANG CHUL-SOO KIM SEUNG HYUN JEON YOUN-WHA KIM BO YOUL CHOI 《International journal of urology》2006,13(2):122-126
AIM: To evaluate the cause of elevated prostate-specific antigen (PSA) in patients with transrectal needle biopsy negative for prostate cancer. METHODS: Serum PSA concentration, prostate volume, and pathologic findings were examined in 223 patients with negative biopsy for prostate cancer. The degree of prostate inflammation was determined by the extent and degree of inflammation shown by biopsy specimens and is expressed as an inflammation score (range: 0-36). RESULTS: A significant correlation was found between PSA concentration and prostate total volume (P=0.0001). Prostate chronic inflammation showed no correlation with PSA concentration (P=0.485, F=0.488). After allocating patients to normal PSA (4 ng/mL) groups, we found that serum PSA concentrations in both groups were predominantly affected by prostate total volume. CONCLUSIONS: An increase in prostate volume appears to be the major contributor to a high serum PSA concentration in patients with negative biopsy for prostate cancer. However, in contrast to previous reports, there was no correlation between the degree of prostate chronic inflammation and serum PSA concentrations. 相似文献